{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:34:37Z","timestamp":1793885677142,"version":"4.8.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.esmoop.2026.108533","type":"journal-article","created":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:41:14Z","timestamp":1793288474000},"page":"108533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"H.","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kenmotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tachihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sutandyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lokeshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-J.","family":"Voon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Samala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-K.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-H.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sriuranpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Reungwetwattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-C.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Soo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.I.","family":"Ladrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.R.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Basade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Rumende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Leighl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2026.108533_bib2","series-title":"Global Cancer Observatory: Cancer Today","year":"2024"},{"key":"10.1016\/j.esmoop.2026.108533_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.esmoop.2026.108533_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102706","article-title":"Challenges of lung cancer control in Asia","volume":"74","author":"Chiu","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108533_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.46234\/ccdcw2025.124","article-title":"Smoking prevalence in urban and rural areas\u2014China, 2024","volume":"7","author":"Zeng","year":"2025","journal-title":"China CDC Wkly"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/jwh.2007.0621","article-title":"Gender differences in smoking behaviors in an Asian population","volume":"17","author":"Tsai","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.esmoop.2026.108533_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/1471-2407-14-406","article-title":"Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea","volume":"14","author":"Park","year":"2014","journal-title":"BMC Cancer"},{"issue":"9877","key":"10.1016\/j.esmoop.2026.108533_bib8","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(13)60854-5","article-title":"Tobacco control in Asia","volume":"381","author":"Mackay","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.esmoop.2026.108533_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1265\/ehpm.23-00292","article-title":"Tobacco usage in the home: a cross-sectional analysis of heated tobacco product (HTP) use and combustible tobacco smoking in Japan, 2023","volume":"29","author":"Odani","year":"2024","journal-title":"Environ Health Prev Med"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108533_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtho.2020.04.028","article-title":"Lung cancer in People\u2019s Republic of China","volume":"15","author":"Gao","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108533_bib11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108533_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.35772\/ghmo.2021.01013","article-title":"Burden of cancer attributable to tobacco smoke in Japan in 2015","volume":"1","author":"Katanoda","year":"2021","journal-title":"GHM Open"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108533_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.21037\/tlcr.2018.05.14","article-title":"Lung cancer in never smokers\u2014the East Asian experience","volume":"7","author":"Zhou","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108533_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-2600(23)00338-7","article-title":"Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study","volume":"12","author":"Chang","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","article-title":"Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108533_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1440-1843.2005.00723.x","article-title":"Lung cancer in Asian women-the environment and genes","volume":"10","author":"Lam","year":"2005","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108533_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jtho.2019.10.022","article-title":"Asian Thoracic Oncology Research Group Expert consensus statement on optimal management of stage III NSCLC","volume":"15","author":"Tan","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5306\/wjco.v8.i1.1","article-title":"Therapeutic management options for stage III non-small cell lung cancer","volume":"8","author":"Yoon","year":"2017","journal-title":"World J Clin Oncol"},{"issue":"18","key":"10.1016\/j.esmoop.2026.108533_bib21","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1111\/1759-7714.14594","article-title":"Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: a retrospective analytical study based on real-world clinical data of the Korean population","volume":"13","author":"Jeon","year":"2022","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","article-title":"Clinical impacts of EGFR mutation status: analysis of 5780 surgically resected lung cancer cases","volume":"111","author":"Suda","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108533_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7174","article-title":"Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: the KINDLE study","volume":"13","author":"Lee","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100866","article-title":"Clinicopathological and demographical characteristics of non-small cell lung cancer patients with ALK rearrangements: a systematic review and meta-analysis","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108533_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/cac2.12593","article-title":"Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study","volume":"44","author":"Li","year":"2024","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108533_bib26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Zer","year":"2025","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108533_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.annonc.2025.04.006","article-title":"ESMO-magnitude of clinical benefit scale version 2.0 (ESMO-MCBS v2.0)","volume":"36","author":"Cherny","year":"2025","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108533_bib28","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108533_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jtho.2019.12.107","article-title":"PD-L1 testing for lung cancer in 2019: perspective from the IASLC Pathology Committee","volume":"15","author":"Lantuejoul","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.esmoop.2026.108533_bib30","article-title":"New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe","volume":"38","author":"Houda","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108533_bib31","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/jcm9072093","article-title":"PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: a pairwise meta-analysis","volume":"9","author":"Garc\u00eda-Gonz\u00e1lez","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib32","first-page":"191","article-title":"Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC","volume":"22","author":"Chen","year":"2025","journal-title":"Cancer Biol Med"},{"issue":"19","key":"10.1016\/j.esmoop.2026.108533_bib33","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2026.108533_bib34","series-title":"Staging Manual in Thoracic Oncology","year":"2024"},{"key":"10.1016\/j.esmoop.2026.108533_bib35","series-title":"TNM Classification of Malignant Tumours","year":"2025"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108533_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jtho.2016.01.024","article-title":"The IASLC lung cancer staging project: summary of proposals for revisions of the classification of lung cancers with multiple pulmonary sites of involvement in the forthcoming eighth edition of the TNM classification","volume":"11","author":"Detterbeck","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"23","key":"10.1016\/j.esmoop.2026.108533_bib37","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1158\/1078-0432.CCR-19-1700","article-title":"Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic approach","volume":"25","author":"Chang","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jtho.2024.11.016","article-title":"Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: recommendations from the international association for the study of lung cancer pathology committee","volume":"20","author":"Chou","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41698-024-00786-5","article-title":"Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution","volume":"9","author":"Wang","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108533_bib40","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.21037\/tlcr-2024-1160","article-title":"Different prognosis of multiple lung cancer identified by 116-gene panel by next-generation sequencing based on an Asian population","volume":"14","author":"Ni","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108533_bib41","article-title":"Consensus on the lung cancer management after third-generation EGFR-TKI resistance","volume":"53","author":"Zhou","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108533_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/jpm15040136","article-title":"The actual role of CPET in predicting postoperative morbidity and mortality of patients undergoing pneumonectomy","volume":"15","author":"Mazzella","year":"2025","journal-title":"J Pers Med"},{"issue":"10335","key":"10.1016\/j.esmoop.2026.108533_bib43","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or sublobar resection for peripheral stage IA non\u2013small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jtcvs.2023.07.008","article-title":"Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: a post hoc analysis of CALGB 140503 (Alliance)","volume":"167","author":"Altorki","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108533_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jtho.2025.03.042","article-title":"Anatomic lung resection is associated with improved survival compared with wedge resection for stage IA (\u22642 cm) NSCLC","volume":"20","author":"Seder","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.11-2501","article-title":"Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan","volume":"143","author":"Chang","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lungcan.2006.09.009","article-title":"Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT","volume":"55","author":"Oh","year":"2007","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108533_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezad222","article-title":"European guidelines for the surgical management of pure ground-glass opacities and part-solid nodules: Task Force of the European Association of Cardio-Thoracic Surgery and the European Society of Thoracic Surgeons","volume":"64","author":"Cardillo","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"issue":"15_suppl","key":"10.1016\/j.esmoop.2026.108533_bib50","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.8561","article-title":"A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin-section computed tomography (JCOG0804\/WJOG4507L)","volume":"35","author":"Suzuki","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtcvs.2020.09.146","article-title":"A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer","volume":"163","author":"Suzuki","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S2213-2600(23)00041-3","article-title":"Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial","volume":"11","author":"Aokage","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108533_bib53","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jjco\/hyab074","article-title":"Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study)","volume":"51","author":"Miyoshi","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jtcvs.2010.11.008","article-title":"Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial","volume":"141","author":"Darling","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108533_bib55","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1245\/s10434-022-11375-w","article-title":"Technical standards for cancer surgery: commission on cancer standards 5.3-5.8","volume":"29","author":"Katz","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108533_bib56","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.21037\/jtd-24-971","article-title":"Impact of lymph node evaluation standard in patients undergoing lung resection for clinical stage IA pulmonary adenocarcinoma and squamous cell carcinoma","volume":"16","author":"Rocco","year":"2024","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.esmoop.2026.108533_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2024.1395884","article-title":"Lymph node dissection in lung cancer surgery: a comparison between robot-assisted vs. video-assisted thoracoscopic approach","volume":"11","author":"Hurley","year":"2024","journal-title":"Front Surg"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib58","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100016","article-title":"Video-assisted thoracoscopic or open lobectomy in early-stage lung cancer","volume":"1","author":"Lim","year":"2022","journal-title":"NEJM Evid"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108533_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107256","article-title":"RoboticAssisted (RATS) versus Video-Assisted (VATS) lobectomy: a monocentric prospective randomized trial","volume":"49","author":"Catelli","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib60","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/SLA.0000000000006073","article-title":"Robotic lobectomy is cost-effective and provides comparable health utility scores to video-assisted lobectomy: early results of the RAVAL trial","volume":"278","author":"Patel","year":"2023","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108533_bib61","article-title":"A Brazilian randomized study: robotic-assisted vs. video-assisted lung lobectomy outcomes (BRAVO trial)","volume":"48","author":"Terra","year":"2022","journal-title":"J Bras Pneumol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108533_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/SLA.0000000000004922","article-title":"Robotic-assisted versus video-assisted thoracoscopic lobectomy: short-term results of a randomized clinical trial (RVlob trial)","volume":"275","author":"Jin","year":"2022","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.00184308","article-title":"ERS\/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)","volume":"34","author":"Brunelli","year":"2009","journal-title":"Eur Respir J"},{"issue":"5 suppl","key":"10.1016\/j.esmoop.2026.108533_bib64","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108533_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","article-title":"Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial","volume":"23","author":"Le Pechoux","year":"2022","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108533_bib66","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.esmoop.2026.108533_bib68","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108533_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-2600(24)00269-8","article-title":"Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial","volume":"13","author":"Yue","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"21","key":"10.1016\/j.esmoop.2026.108533_bib70","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.esmoop.2026.108533_bib71","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108533_bib72","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.22.02186","article-title":"Adjuvant osimertinib for resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer: updated results from the phase III randomized ADAURA trial","volume":"41","author":"Herbst","year":"2023","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.esmoop.2026.108533_bib73","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa2310532","article-title":"Alectinib in resected ALK-positive non-small-cell lung cancer","volume":"390","author":"Wu","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2026.108533_bib74","series-title":"Ensartinib as adjuvant therapy in patients (pts) with stage IB\u2013IIIB ALK-positive (ALK+) non-small cell lung cancer (NSCLC) after complete tumor resection: the phase III randomized ELEVATE trial","author":"Yue","year":"2025"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108533_bib76","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108533_bib77","doi-asserted-by":"crossref","first-page":"S1301","DOI":"10.1016\/j.annonc.2023.10.057","article-title":"LBA61 durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: final analysis from PACIFIC-6","volume":"34","author":"Garassino","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.108533_bib78","doi-asserted-by":"crossref","first-page":"S1624","DOI":"10.1016\/j.annonc.2024.10.643","article-title":"LBA6 PACIFIC-5: a phase III study of consolidation durvalumab (D) in patients (pts) with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy (cCRT or sCRT)","volume":"35","author":"Wu","year":"2024","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108533_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jtho.2023.02.009","article-title":"Brief report: durvalumab after chemoradiotherapy in unresectable stage III EGFR-mutant NSCLC: a post hoc subgroup analysis from PACIFIC","volume":"18","author":"Naidoo","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108533_bib80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.esmoop.2026.108533_bib81","series-title":"India Health System Review","year":"2022"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108533_bib83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/ijmr.IJMR_4251_20","article-title":"Comprehensive value-based cancer care in India: opportunities for systems strengthening","volume":"154","author":"Bhadelia","year":"2021","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252240","article-title":"High TB burden and low notification rates in the Philippines: the 2016 national TB prevalence survey","volume":"16","author":"Lansang","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108533_bib87","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jtho.2020.11.020","article-title":"Lung cancer in Singapore","volume":"16","author":"Ang","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"10305","key":"10.1016\/j.esmoop.2026.108533_bib88","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(21)00252-X","article-title":"Singapore\u2019s health-care system: key features, challenges, and shifts","volume":"398","author":"Tan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.esmoop.2026.108533_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1108\/S0731-2199(2009)0000021006","article-title":"The equity impact of the universal coverage policy: lessons from Thailand","volume":"21","author":"Prakongsai","year":"2009","journal-title":"Adv Health Econ Health Serv Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:12:57Z","timestamp":1793884377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926024786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2059702926024786"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108533","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108533"}}